SCHEMBL8852149

SCHEMBL8852149

CCNCCN(CC)C1CC[N]CC1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SAT1 P21673 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8851142 0.90 SAT1 (0.37) SAT1
SCHEMBL8851758 0.84 PRMT3 (0.32)
SCHEMBL14645041 0.80 SAT1 (0.36) SAT1
SCHEMBL8852160 0.80 SAT1 (0.32) SAT1
SCHEMBL8851153 0.79
SCHEMBL8852154 0.79 SLC6A2 (0.39) SAT1
SCHEMBL8852225 0.78 TSHR (0.36) SAT1
SCHEMBL293248 0.78
SCHEMBL8851216 0.77 SIGMAR1 (0.30)
SCHEMBL8851646 0.76 SAT1 (0.30) SAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5618814-A Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds DR. KARL THOMAE GMBH (DE) 1997-04-08 US disclosed
EP-0645390-A1 Trisubstituted pyrimido 5,4-d pyrimidines for modulating multidrug resistance, drugs containing these compounds and processes for their preparation Dr. Karl Thomae GmbH (DE) 1995-03-29 EP disclosed